Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Other financing activities (2020 - 2025)

Exagen's Other financing activities history spans 3 years, with the latest figure at $199000.0 for Q3 2025.

  • For Q3 2025, Other financing activities changed N/A year-over-year to $199000.0; the TTM value through Dec 2025 reached $869000.0, changed N/A, while the annual FY2025 figure was $869000.0, N/A changed from the prior year.
  • Other financing activities reached $199000.0 in Q3 2025 per XGN's latest filing, down from $605000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.2 million in Q1 2021 to a low of -$4.4 million in Q4 2021.